Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
National University Corporation Kagawa University is currently active in the Biotechnology & Pharmaceuticals technology area. The portfolio contains 3 pending office actions. These matters are handled by a matching count of distinct examiners, ensuring that the workload is spread across different individuals. The prosecution occurs within 3 distinct art units, which points to a range of technical specializations for the university's filings.
The busiest examiner is WHITE, ASHLEY TAYLOR, who is assigned 1 busiest examiner pending office action. Because the total number of pending office actions is the same as the count of distinct examiners, each examiner is responsible for a unique case. The 1 busiest examiner pending action represents the maximum load for any individual examiner in this set. The Biotechnology & Pharmaceuticals classification suggests the applications involve complex life sciences subject matter.
Practitioners should note that the different art units may have different allowance rates and procedural norms. The examiners will each bring a unique perspective to the pending office actions. Managing the different art units requires a flexible approach to patent prosecution. The role of WHITE, ASHLEY TAYLOR is limited to the current pending matter at this time.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WHITE, ASHLEY TAYLOR | 1 | 25.0% | +46.7% |
| RODRIGUEZ, RAYNA B | 1 | 33.6% | +19.2% |
| HUTSON, RICHARD G | 1 | 65.1% | +53.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18039405 | NOVEL L-RHAMNOSE ISOMERASE | WHITE, ASHLEY TAYLOR | 2d overdue |
| 17295253 | NOVEL KETOSE 3-EPIMERASE | HUTSON, RICHARD G | 6d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18039405 | NOVEL L-RHAMNOSE ISOMERASE | WHITE, ASHLEY TAYLOR | 2d overdue |
| 17295253 | NOVEL KETOSE 3-EPIMERASE | HUTSON, RICHARD G | 6d |
| 17599252 | OSMOTIC PRESSURE REGULATOR FOR PERITONEAL DIALYSATE CONTAINING D-ALLOSE AND/OR D-ALLULOSE | RODRIGUEZ, RAYNA B | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 1628 | 1 |
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18039405 | NOVEL L-RHAMNOSE ISOMERASE | WHITE, ASHLEY TAYLOR | 1653 | §101§103 | Final Rejection | 2d overdue | Pending | May 30, 2023 |
| 17599252 | OSMOTIC PRESSURE REGULATOR FOR PERITONEAL DIALYSATE CONTAINING D-ALLOSE AND/OR D-ALLULOSE | RODRIGUEZ, RAYNA B | 1628 | §103 | Final Rejection | — | Pending | Sep 28, 2021 |
| 17295253 | NOVEL KETOSE 3-EPIMERASE | HUTSON, RICHARD G | 1652 | §102§112 | Final Rejection | 6d | Pending | May 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial